PTC THERAPEUTICS, INC.
Last · —$59.67-0.25 (-0.42%)live · yahoo · 1h ago
Market cap$5.13B—
P/E · TTM71.7fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | $806.8M |
|---|---|
| Operating income | $-302.6M |
| Net income | $-363.3M |
| Free cash flow | $-114.2M |
| Operating margin | -37.5% |
| Net margin | -45.0% |
| Period | 2024 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2025-02-27
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -45.0%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -13.3%
- Rd Intensity High — R&D/Revenue 66.2%
Upcoming earnings
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
$0.30
Est. revenue
302.8M